Related Experiment Video
Updated: May 26, 2026

Working with Human Tissues for Translational Cancer Research
Published on: November 26, 2015
Informed consent from cognitively impaired persons participating in research trials: comparative law observations
1Unità di Bioetica, Presidenza, Istituto Superiore di Sanità, Via Giano della Bella 34, Rome, Italy. carlo.petrini@iss.it
Abstract:
This article addresses the ethical requirements to be considered when conducting clinical trials involving human subjects whose mental condition limits their ability to understand the information and to express fully autonomous and informed consent. It does not address other categories of vulnerable persons, such as children, or advanced directives concerning end-of-life care. There are many ethical issues entailed in clinical trials involving subjects with mental disabilities: how to obtain informed consent, balancing risks and benefits, balancing individual benefits with collective scientific and social interests, legal representation and many more. This article focuses on the issues surrounding the concept of minimal risk and the relationship between informed consent and risk. These issues are addressed with particular emphasis on the regulations adopted by the European Union and the federal government of the United States of America. The conclusion proposes a list of working criteria.
More Related Videos
08:42A Familiarization Protocol Facilitates the Participation of Children with ASD in Electrophysiological Research
Published on: July 31, 2017
07:01Working Memory Training for Older Participants: A Control Group Training Regimen and Initial Intellectual Functioning Assessment
Published on: September 20, 2020
Related Concept Videos
Ethics in Research
Nurses' Legal Responsibilities I
The legal responsibilities of a nurse regarding informed consent include the following:
Blind Procedures
Psychosurgery
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
Blinding
Bioavailability Study Design: Healthy Subjects Versus Patients